Alerta De Seguridad para GEM Premier 4000 PAK Cartridges for Use on the GEM Premier 4000 System

Según Department of Health, este evento ( alerta de seguridad ) involucró a un dispositivo médico en Hong Kong que fue producido por Instrumentation Laboratory Company.

¿Qué es esto?

Las alertas proporcionan información importante y recomendaciones sobre los productos. Aunque se haya emitido una alerta, esto no significa necesariamente que el producto se considera peligroso. Las alertas de seguridad, dirigidas a trabajadores de la salud y a usuarios, pueden incluir retiro de equipos. Pueden ser escritas por los fabricantes, pero también por funcionarios del área de salud.

Más información acerca de la data acá
  • Tipo de evento
    Safety alert
  • Fecha
    2011-08-03
  • País del evento
  • Fuente del evento
    DH
  • URL de la fuente del evento
  • Notas / Alertas
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • Notas adicionales en la data
    Medical Device Safety Alert
  • Causa
    Fda class i recall: gem premier 4000 pak cartridges for use on the gem premier 4000 system it has come to our attention that the u.S. food and drug administration (fda) has issued an class i recall to remind healthcare providers and patients that gem premier 4000 pak cartridges for use on the gem premier 4000 portable critical care system, which is manufactured by instrumentation laboratory company, may give inaccurate results. potassium test results on the gem premier 4000 are too low when compared to a reference analyzer; with biases exceeding the allowable error claim of plus or minus 0.5 mmol/l by as much as 2.0 mmol/l. use of this product may lead to inappropriate patient treatment and may cause serious adverse health consequences, including death. to avoid this, the manufacturer recommended customers to follow the instructions to disable the potassium test to eliminate the potential of erroneous result reporting. according to the local supplier, hong kong is affected. the local supplier has contacted the affected customers for corrective actions for details, please refer to the following link: http://www.Fda.Gov/safety/medwatch/safetyinformation/ safetyalertsforhumanmedicalproducts/ucm266113.Htm if you are in possession of the affected product, please contact your supplier for necessary actions.

Device

Manufacturer